TARA FY 2016 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$216M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$123,000

Operating Income

-$29M

Net Income

-$29M

EPS (Diluted)

$-68.90

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$44M

Total Liabilities

$5M

Stockholders' Equity

$38M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$123,000	-$57,000	-115.8%
Operating Income	-$29M	-$21M	-37.5%
Net Income	-$29M	-$21M	-33.4%